Our work here has begun to explore the expression of PSMA in the neovascular of mouse models of breast cancer and can enable other use of these models to study PSMA targeted agents for image guided surgery, therapeutics, radiosensitizers and so on in non-prostate cancers in animal models. This evidence concerns the gene FOLH1 and prostate cancer.